Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m -carboxycinnamic acid bis -hydroxamide

Molecular and Cellular Biochemistry

Volumn 312, Issue 1-2, 2008, Pages 47-60

  Majumdar, Gipsy ^a,b   Johnson, I Maria ^a   Kale, Santosh ^a   Raghow, Rajendra ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene expression; Histone modifications; Myosin heavy chain genes; PTEN; Signal transduction

Indexed keywords

3 CARBOXYCINNAMIC ACID BIS HYDROXAMIDE; ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; DESMIN; GENOMIC DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 18; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SPACER DNA; TENSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SIZE; CELL STRUCTURE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC REGULATION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; NONHUMAN; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; CARDIOTONIC AGENTS; CELL LINE; CINNAMATES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HEART; HISTONE CODE; HISTONE DEACETYLASES; HUMANS; HYPERTROPHY; INTERLEUKIN-18; MYOCARDIUM; ORGAN SPECIFICITY; PHENYLEPHRINE; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; VENTRICULAR MYOSINS;

EID: 42149139641     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9720-x     Document Type: Article

References (45)

1. Morel JC, Park CC, Kumar P, Koch AE (2001) Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest 81:1371-1383
2. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393-1401
3. Dinarello CA, Fantuzzi G (2003) Interleukin-18 and host defense against infection. J Infect Dis 187:S370-384
4. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474
5. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195:245-257
6. Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, Chvatchko Y, Tedgui A (2002) Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88:467-469
7. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Okamura H, Iwasaki T (2002) Increased circulating interleukin-18 in patients with congestive heart failure. Heart 88:296-297
8. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M (2005) Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem 280: 4553-4567
9. Woldbaek PR, Sande JB, Stromme TA, Lunde PK, Djurovic S, Lyberg T, Christensen G, Tonnessen T (2005) Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol 289:H708-H714
10. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600
11. Frey N, Olson EN (2003) Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol 65: 45-79
12. McKinsey TA, Olson EN (2004) Dual roles of histone deacetylases in the control of cardiac growth. Novartis Found Symp 259:132-141; discussion 141-145, 163-169
13. Backs J, Olson EN (2006) Control of cardiac growth by histone acetylation/deacetylation. Circ Res 98:15-24
14. Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381-2402
15. Langst G, Becker PB (2004) Nucleosome remodeling: One mechanism, many phenomena? Biochim Biophys Acta 1677:58-63
16. Imbalzano AN, Xiao H (2004) Functional properties of ATP-dependent chromatin remodeling enzymes. Adv Protein Chem 67:157-179
17. de la Cruz X, Lois S, Sanchez-Molina S, Martinez-Balbas MA (2005) Do protein motifs read the histone code? Bioessays 27:164-175
18. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J 370:737-749
19. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21:1790-1802
20. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579-2588
21. Kook H, Lepore JJ, Gitler AD, Lu MM, Wing-Man Yung W, Mackay J, Zhou R, Ferrari V, Gruber P, Epstein JA (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112:863-871
22. Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, Robertson AD, Bristow MR (2002) Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med 8:750-760
23. Deng X, Yellaturu C, Cagen L, Wilcox HG, Park EA, Raghow R, Elam MB (2007) Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1). J Biol Chem 282:17517-17529
24. Majumdar G, Harrington A, Hungerford J, Martinez-Hernandez A, Gerling IC, Raghow R, Solomon S (2006) Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells. J Biol Chem 281:3642-3650
25. Bookout AL, Mangelsdorf DJ (2003) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1:e012
26. Richon VM, Zhou X, Secrist JP, Cordon-Cardo C, Kelly WK, Drobnjak M, Marks PA (2004) Histone deacetylase inhibitors: Assays to assess effectiveness in vitro and in vivo. Methods Enzymol 376:199-205
27. Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, Elam MB (2005) Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385:207-216
28. Chandrasekar B, Mummidi S, Valente AJ, Patel DN, Bailey SR, Freeman GL, Hatano M, Tokuhisa T, Jensen LE (2005) The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J Biol Chem. 280: 26263-26277
29. Glaser KB, Li J, Pease LJ, Staver MJ, Marcotte PA, Guo J, Frey RR, Garland RB, Heyman HR, Wada CK, Vasudevan A, Michaelides MR, Davidsen SK, Curtin ML (2004) Differential protein acetylation induced by novel histone deacetylase inhibitors. Biochem Biophys Res Commun 325:683-690
30. Haddad F, Bodell PW, Qin AX, Giger JM, Baldwin KM (2003) Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem 278:37132-37138
31. Pan L, Lu J, Wang X, Han L, Zhang Y, Han S, Huang B (2007) Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer 109:1676-88
32. Kaneda R, Ueno S, Yamashita Y, Choi YL, Koinuma K, Takada S, Wada T, Shimada K and Mano H (2005) Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. Circ Res 97: 210-218
33. Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S (2004) Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J Biol Chem 279:7685-7691
34. Chen CS, Weng SC, Tseng PH, Lin HP (2005) Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. J Biol Chem 280:38879-38887
35. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210-1216
36. Eberharter A, Becker PB (2002) Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3:224-9
37. Kouzarides T (2002) Histone methylation in transcriptional control. Curr Opin Genet Dev. 12:198-209
38. Sims RJ III, Nishioka K, Reinberg D (2003) Histone lysine methylation: A signature for chromatin function. Trends Genet 19:629-639
39. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA (2005) Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell 19:381-391
40. Miao F, Natarajan R (2005) Mapping global histone methylation patterns in the coding regions of human genes. Mol Cell Biol 25:4650-4661
41. Ruthenburg AJ, Li H, Patel DJ, Allis CD (2007) Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8:983-994
42. Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA (2007) Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 13:324-331
43. Klose RJ, Zhang Y (2007) Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8:307-318
44. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693-705
45. Lee KK, Workman JL (2007) Histone acetyltransferase complexes: One size doesn't fit all. Nat Rev Mol Cell Biol 8:284-295